Zamann Pharma Support offers expert-led medical device gap assessment services tailored to evaluate a company’s readiness for EU registration. Our comprehensive assessments identify discrepancies between current operational practices and the regulatory standards defined by the MDR and IVDR. By reviewing internal documentation, procedures, and compliance systems, we uncover process inefficiencies and areas of non-conformance. The goal is to equip our clients with clear, actionable insights and a prioritized plan for remediation. This ensures they not only meet EU requirements but also establish a sustainable compliance framework for ongoing registration and audit success.
A thorough medical device gap assessment starts with an in-depth review of the client’s existing documentation and operational workflows. We analyze SOPs, work instructions, registration maps, and procedural controls for consistency with MDR expectations. Our experts trace each step in the EU registration journey—from initial planning to submission—to identify redundancies, bottlenecks, or missing documentation. We then deliver a process map that visualizes workflow weaknesses and opportunities for improvement. This assessment ensures companies are operating with the right documentation infrastructure to support fast, accurate, and regulator-ready medical device submissions in the EU.
As part of every medical device gap assessment, we conduct a structured compliance comparison between the client’s current practices and EU regulatory frameworks. Our consultants assess policies and processes against the MDR, IVDR, ISO 13485, and relevant FDA/EMA expectations. This includes risk assessments, validation protocols, QMS documentation, and labeling reviews. We identify high-risk gaps, evaluate the potential for non-compliance, and recommend corrective measures. The outcome is a comprehensive view of how far the client’s current state deviates from regulatory expectations—empowering them to make timely, effective changes before submission or audit.
The final step in a medical device gap assessment is detailed reporting of all identified deficiencies, including supporting analysis and remediation planning. We categorize gaps by impact area—such as documentation, validation, risk management, and quality systems—then trace root causes using industry-proven diagnostic tools. Our reports include prioritized action plans with timelines, responsible owners, and resource estimates for closing each gap. These deliverables serve as an implementation roadmap to restore and enhance regulatory alignment. By following our structured remediation approach, clients significantly reduce approval delays and improve audit outcomes.
Understanding and processing the EU regulations for Medical Devices and IVDs requires precision and insight. Our support is personalized to guide your product through the EU regulatory landscape, from initial classification to successful registration.
Zamann brings extensive experience with EU Medical Devices and IVDs regulations, offering reliable expertise to simplify the path to compliance. We provide strategic guidance, ensuring your devices are safely and efficiently brought to the market with confidence.
